at least 50% improvement. The average dosage for 50% to 90% and at least 90% improvement was 1.9 mg/d and 2.3 mg/d, respectively. Four patients (17%) reported minor adverse effects, with the most common being drowsiness (2 patients), which resolved with time.
The mean (range) time to at least 50% and 90% disease control was 2.4 (0.9-5.0) months and 6.6 (3.2-13.1) months, respectively. Of patients who achieved baseline function, all had median dosages of 2 mg/d and remained in remission at their last visit, with a mean (range) remission time of 10.0 (3.0-18.2) months.
When comparing patients receiving median dosages of 1 mg/d and 2 mg/d, the median time to partial remission for both groups was 2.1 months, with a median (interquartile range [IQR] ) duration of response of 2.3 (1.9-2.6) months and 4.7 (2.9-12.6) months, respectively. Of patients with median dosages of 1 mg/d, 50% achieved partial responses. Among patients with median dosages of 2 mg/d, 10 (71%) achieved at least partial responses and 7 (50%) achieved baseline function, with a median (IQR) duration of remission of 9.9 (3.7-15.4) months.
Discussion | Research on antipsychotic therapies for Morgellons disease remains limited. Pimozide, a typical antipsychotic, was historically favored, partly because of its antipruritic properties. 1 Nowadays, as with other medications, the decision between pimozide and other antipsychotics involves considering their efficacy and profiles of adverse effects. 1, 4 Our findings, with 63% of patients achieving partial or full remission, are concordant with published results using pimozide and atypical antipsychotics, although direct comparisons are difficult owing to heterogeneity of the studies. 1 Moreover, our finding that a higher dosage of trifluoperazine is associated with a longer duration of response and a greater percentage of patients achieving remission suggests a positive dose-response relationship.
Similar to the antipruritic effects of pimozide, low-dose trifluoperazine has analgesic effects from its opioidreceptor system interactions. 5 Moreover, consistent with our observations, trifluoperazine at low dosages up to 4 mg/d has limited to no adverse effects. 6 Given the comparative safety, cost-effectiveness, and clinical efficacy, we propose the use of low-dose trifluoperazine for Morgellons 
Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis
Herpes zoster (HZ) is caused by reactivation of latent varicella zoster virus (VZV). Risk increases with waning cell-mediated immunity secondary to advanced age and immunosuppression. Some of the systemic agents used in moderate-to-severe psoriasis may be associated with increased HZ risk, though studies are conflicting, and data among patients with psoriasis is lacking. 1 In patients with systemically treated psoriasis, the association between medication use and HZ risk remains poorly characterized, especially with regard to biologic vs nonbiologic therapy. This study aimed to estimate HZ incidence rates (IR) among systemically treated patients with psoriasis, comparing patients treated with biologic vs nonbiologic agents, in a community-based health care delivery setting. Results | Cohort members were followed for a mean of 5.3 person-years. Nonbiologic users were older than biologic users, and women were less likely to have used biologics (Table 1) .
Of the 5889 participants with systemically treated psoriasis, 291 had HZ diagnosed during follow-up. Crude IRs showed that, compared with those on no systemic therapy at the time of HZ diagnosis (IR, 8.6; 95% CI, 7.1-10.0), those on systemic therapy had a statistically nonsignificant increased HZ risk (IR, 10.2; 95% CI, 8.6-11.8; P= .14) ( Table 2) . After adjusting for age and sex, there were no significant differences between those receiving no systemic therapy (aIR, 6.1; 95% CI, 4. Letters psoriasis. [3] [4] [5] Crude point estimates did not suggest an increased HZ risk in systemically treated patients with psoriasis, and we found no significant differences in HZ risk among those exposed to biologic vs nonbiologic therapy after adjusting for age and sex.
Limitations. limitations of the study include lack of data on disease severity and potentially limited generalizability to other healthcare settings.
Conclusions | Among a cohort of patients with moderate-tosevere psoriasis who were treated with a systemic agent on cohort entry, we found no significant differences in HZ risk at time of HZ diagnosis among those treated with systemic therapy vs no systemic therapy, and among systemically treated patients, among those treated with biologics versus no biologic agents. Our results are similar to those of a recently published retrospective cohort study 4 that found no significant association between biologics as single agents and adjusted HZ risk in patients with psoriasis. We previously reported an increased risk of bacterial skin and soft tissue infections among those treated with biologics compared with those treated with nonbiologics in this cohort. 6 Biologics block the activity of cytokines such as TNF-α, which plays a role in protecting against bacterial infections and inhibiting reactivation of latent viruses. Incident rates of HZ were increased in systemically treated patients with psoriasis as compared with the general population. However, we found no significant differences in HZ risk among those exposed to biologic vs nonbiologic therapy after adjusting for age and sex. Our results suggest that among systemically treated psoriasis patients, biologics may preferentially inhibit immune mechanisms specific for bacterial defense while sparing cell-mediated immune responses specific for maintaining VZV latency. have detected carcinogenic chemicals on firefighter skin and gear following fire-incident response. There is limited research on risk factors and occupational hazards related to skin cancer in the firefighter workforce. We examine skin cancer history, skin cancer screening, and sun protection habits among active Florida firefighters.
Methods | The Annual Cancer Survey (ACS) research project of the Firefighter Cancer Initiative launched with a 127-item comprehensive cancer questionnaire administered via REDCap to a nonprobabilistic sample of firefighters and/or paramedics employed in South Florida. We present ACS data collected during the first 12 months of this cross-sectional, convenience study (http://sylvester.org/firefighters). Firefighters were invited and consented by the study team to complete the ACS using a secure iPad device during their regular work shift. Standardized subjective measures assessing for doctordiagnosed skin cancer, type of skin cancer, frequency of sunburn, tanning bed use in their lifetime, health insurance status, skin cancer screening behavior, and sociodemographic characteristics, as well as job characteristics, were analyzed. Multivariate and univariate logistic regression models were fitted to predict history of skin cancer and sun protection practices. Adjusted odds ratios (aOR) and unadjusted odds ratios (uOR) were calculated with 95% CIs. This study was approved by the University of Miami institutional review board.
Results | Among the 2505 surveyed firefighters, 2399 (95.8%) completed the survey; mean (SD) age was 41.7 (8.5) years and mean (SD) time of employment as a firefighter was 15.1 (8.2) years (Table 1) . Overall, 109 cases of skin cancer were reported, affecting 4.5% of respondents: 17 firefighters (0.7%) had melanoma; 84 (3.5%), nonmelanoma; and 18, unknown skin cancer type. The mean (SD) age of skin cancer diagnosis was 42.2 (6.8) years for melanoma, 38.3 (10.8) years for nonmelanoma, and 42.4 (8.5) years for unknown skin cancer type. In terms of sun protection practices, wearing sunscreen when outdoors was the most commonly reported behavior among all participants and lowest among unknown skin cancer types. Respondents with skin cancer and the overall firefighter sample reported the least use of long pants while outdoors compared with the participants without skin cancer. Non-Hispanic ethnicity (aOR, 3.25; 95% CI, 1.74-6.07) and increased age (aOR 1.07; 95% CI, 1.03-1.11) were significant predictors of a skin cancer diagnosis in the firefighter sample ( Table 2) . Firefighters with a history of skin cancer were significantly more likely to use sunscreen most of the time or always when outdoors (uOR, 1.91; 95% CI, 1.30-2.81).
Discussion | Our results suggest that a high percentage of younger firefighters have skin cancer and that there may be a higher risk for skin cancer among firefighters. This sample had an elevated prevalence of melanoma (0.7%) compared with the Florida adult melanoma prevalence found in other epidemiologic studies (0.011%). 3 Furthermore, the median age of diagnosis for melanoma among the sampled firefighters (42 years) was younger than median age of diagnosis in the general US Abbreviation: ND, no data. a Column percentages (differences in subtotal due to item nonresponse or missing values in the sample). b Row percentages (differences in subtotal due to item nonresponse or missing values in the sample). c Proportion of firefighters who follow these sun protection practices "always" or "most of the time" when in the sun for more than 1 h.
Letters population (64 years). 4 The increased skin cancer rates and earlier presentation may be attributable to carcinogenic occupational exposures; however, non-work-related ultraviolet light exposure may also contribute. Better understanding of these carcinogens is needed to inform best practices for protection. For most skin cancer screening and sun protection practices, firefighters with a history of skin cancer had higher rates of adherence than firefighters without a history of skin cancer. This firefighter sample showed a higher rate of skin checks compared with state-wide statistics on skin cancer screening. 5 Compared with the US national average, firefighters reported a lower proportion of ever using a tanning bed, yet the rate is still high representing an opportunity for education and behavior modification. 6 Despite the potentially increased skin cancer risk, skin cancer screening and sun protection habits could be improved for firefighters with and without skin cancer diagnoses. Future research is warranted to further investigate skin cancer risk and mortality among firefighters and to identify occupational hazards associated with this excess risk. 
Assessment of the Diameter of Pigmented Skin Lesions With and Without a Ruler
Assessing skin lesion diameter is a key component of the ABCDE (Asymmetrical shape, Border, Color, Diameter, and Evolution) criteria to evaluate lesions concerning for melanoma. 1 To our knowledge, the ability of medical trainees and practitioners to estimate lesion size with and without the aid of a ruler has not been previously described. This study seeks to determine the accuracy with which medical students, internal medicine residents, and dermatology residents, fellows, and faculty can estimate the diameter of skin lesions in clinical photographs.
Methods | Study participants included medical students; internal medicine residents; and dermatology residents, fellows, and faculty at Northwestern University Feinberg School of Medicine. Survey response implied informed consent for inclusion in the study, and study approval was obtained from the Northwestern University institutional review board. Survey data was collected anonymously using online Research Electronic Data Capture surveys (Vanderbilt) and paper surveys from August 4 to August 27, 2017. Participants responded to a survey on their use of rulers in the clinic and their confidence in size estimation of skin lesions, and then selected the diameter of 12 lesions in clinical photographs as follows: 4 lesions that included a ruler in the image, 4 lesions that included an anatomic landmark, and 4 lesions that included neither ruler nor landmark (Figure) . All statistical analyses were performed in R 3.4.1 (R Foundation). The Kruskal-Wallis test was performed to assess group differences between medical students, internal medicine residents, and dermatology residents, fellows, and faculty for 3 sets of images with post hoc pairwise comparisons conducted with the Dunn test for multiple comparisons (Table) . Post hoc analysis used the Bonferroni correction and set significance at P = .05.
Results | The dermatology cohort was more likely to carry rulers and measure suspicious lesions in clinic compared with the internal medicine and medical student cohorts (Table) . Initial confidence in estimating lesion diameter prior to the test was similar among the 3 groups with mean Likert scale values of 2.7, 3.1, and 3.9 for the medical student, internal medicine resident, and dermatology participants, respectively.
For images that included a ruler, 39 medical students estimated the diameter of 107 of 156 lesions (69%) correctly within 1 mm; 27 internal medicine residents 79 of 108 lesions (73%); and 12 dermatology participants, 34 of 48 lesions (71%). There was no statistically significant difference among groups (P = .73). For images with an anatomic landmark, medical students scored 71 of 156 lesions (46%) correctly within 1 mm; internal medicine, 55 of 108 lesions (51%); and dermatology, 23 of 48 lesions (48%); there was no significant difference among groups (P = .82). For images with no ruler and no anatomic landmark, medical students scored 36 of 156 lesions (23%) correctly; internal medicine 20 of 108 lesions (19%); and dermatology, 25 of 48 lesions (52%), and there was statistical significance between groups (P = .003) (Table) . Pairwise post hoc analysis shows a significant difference between the dermatol- ogy cohort and internal medicine cohort (P = .003) and between dermatology and student cohorts (P = .02). After receiving the correct responses, participants indicated that they were more likely to measure suspicious lesions with a ruler, with mean (SD) Likert scale score of 3.8 (0.9) (P = .04).
Discussion | All participants in this study were most accurate in assessing diameter in images with a ruler, and most participants were accurate estimating the diameter in images with an anatomic landmark and no ruler. The dermatology cohort was most accurate in assessing diameter in images with no landmark and no ruler but only estimated 52% of lesions correctly within 1 mm. Prior studies [2] [3] [4] [5] have investigated the ability of general practitioners and dermatologists to assess and triage pigmented lesions using photographs that did not include a ruler, but that we know of, this is the first to evaluate estimation accuracy of providers for skin lesions. The ABCDEs have become a well-established grading system for the evaluation of suspicious skin lesions. The diameter criterion of 6 mm for pigmented lesions is a clinically useful guideline to assess for malignant potential, 1 and assessing diameter is crucial for both dermatologists and nondermatologists to appropriately triage lesions. Furthermore, accurate size estimation also underpins the clinician's ability to accurately assess lesion evolution. This study shows that an accurate clinical assessment of lesion size requires the use of a ruler for all physicians, including dermatologists, and that by simply increasing physician awareness of this potential pitfall is sufficient to compel change. 
OBSERVATION Noninvasive Gene Expression Testing in Amelanotic Melanoma
Not missing melanomas in daily practice keeps dermatologists up at night and is a challenge even for dermatologists who see pigmented lesion cases regularly. Report of a Case | A woman in her 20s with a family history of melanoma presented with a 10 × 11-mm pink papule close to her medial right ankle (Figure) . She had no clear recollection of how long the lesion had been present or if it had changed. A suggested surgical biopsy was refused, but the patient agreed to a noninvasive adhesive patch biopsy and gene expression testing. 1, 2 This test revealed detectable levels of LINC00518 consistent with the gene expression observed in melanoma. The test's second target gene, PRAME, was not detected. After being informed that the detection of 1 or both of these target genes was consistent with melanoma, the patient agreed to undergo a shave biopsy to confirm the diagnosis and provide information on desirable excision margins. Histopathologic analysis established a diagnosis of malignant melanoma with a Breslow thickness of 0.6 mm. The nonulcerated melanoma was found arising over an intradermal nevus and blending with it. Under staining, the tumor was found to be positive for HMB45. 
Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare life-threatening cutaneous drug reactions. The pathogenesis is imperfectly understood and includes genetic factors. 1 Pregnant women with SJS or TEN are a unique subset, and both conditions can simultaneously affect the mother and fetus. [2] [3] [4] There are no data on the risk of SJS or TEN in a newborn of a mother who develops the condition during pregnancy if soon after delivery the newborn is given the same drug that triggered the mother's reaction. We report the case of a pregnant woman with SJS whose newborn was successfully treated with the drugs responsible for his mother's SJS.
Report of a Case | A 35-year-old woman at 33 weeks' gestation received pyrimethamine and sulfadiazine 5 weeks after being diagnosed with toxoplasmosis seroconversion (positive findings for IgG and IgM antitoxoplasma antibodies). The prenatal diagnosis of congenital toxoplasmosis was also confirmed by real-time polymerase chain reaction analysis of amniotic fluid. Two weeks after initiation of the treatment, the woman presented to the emergency department with skin and mucous membrane lesions. No other drugs had been used. Serological test results were negative for human immunodeficiency virus and Mycoplasma pneumoniae. Physical examination revealed an erythematous eruption covering 8% of the body surface area, and detachment affected 5% of the body surface area (Figure) . Eyes, mouth, and genital mucous membranes showed hemorrhagic erosions. Diagnosis of SJS was considered most likely.
Treatment with pyrimethamine and sulfadiazine was stopped, both drugs being involved in drug-induced SJS, even though imputability of sulfadiazine was higher.
5 A 3-mm punch biopsy of the skin revealed full-thickness epidermal necrosis with subepidermal separation, consistent with SJS. Direct immunofluorescence findings were negative. Because of the rapid extension of the disease, cesarean delivery was performed. The newborn was healthy, without signs of SJS or TEN. Pediatricians inquired whether the newborn could be treated with the 2 drugs that caused the SJS in the mother to treat his congenital toxoplasmosis. No similar case was available in the literature on which to base a treatment decision. However, because of the severe prognosis of congenital toxoplasmosis and the absence of other efficacious drugs, the consensus was reached to give the drugs to the newborn under medical care. No signs of SJS or TEN appeared in the infant during 1 year of treatment. The mother recovered and was healthy 2 years later without sequelae.
Discussion | Few cases of SJS or TEN in pregnancy have been reported, with 1 known report of concomitant fetal/newborn involvement. 3 Different mechanisms have been suggested for transmission of SJS or TEN from mother to fetus: predisposing genetic factors or the mother's drug-specific cytotoxic T cells circulating into the fetus's bloodstream. 3 Because no similar data were available, it was not known whether the culprit
Figure. Clinical Appearance of Amelanotic Melanoma
A pink papule is present anterior of the medial ankle.
Letters drugs could be used to treat the newborn of a mother who developed SJS during pregnancy, and the decision was difficult to make. However, postnatal congenital toxoplasmosis treatment was necessary for the newborn to improve clinical outcome. Because of lack of data regarding optimal second-line therapy drugs, the decision was made to give the newborn pyrimethamine and sulfadiazine. Fortunately, the infant did not experience any cutaneous reactions to the drugs or toxoplasmosis sequelae. Subsequently, Knight et al 2 have reported similar cases with nevirapine without incident in the treated newborns. 2 The absence of newborn involvement despite exposure to the mother's SJS causative drugs may suggest that critical factors mediating SJS and TEN in the mother do not pass on to the neonates. Noteworthy, patients with erythema-multiforme-like eruptions due to cutaneous toxoplasmosis have been rarely reported. 6 In the present case, this diagnosis was ruled out because of the onset of skin lesions more than 7 weeks after toxoplasmosis seroconversion. The present case is a single case with successful and safe treatment of the newborn, it and may help others facing a similar decision. Nevertheless, the balance of risk and alternatives should always be considered in such cases.
Optical Coherence Tomography Features of Dermatophytoma
Dermatophytoma was first described in 1998 to complicate toenail infections and is characterized by fungal elements compacted into a fungal ball. 1 Clinically, it appears as a dense white or yellow linear or round white patch within the nail plate. Cutting back the overlying nail plate reveals a hyperkeratotic mass that can be easily removed because it is not adherent to the nail plate or nail bed, and histologic analysis reveals a dense mass of abnormal-appearing, densely walled, dermatophyte hyphae. 1,2 The standard diagnostic test for onychomycosis involves clinical suspicion and at least 1 positive finding on a laboratory test, but the diagnosis of dermatophytoma is much less straightforward and has rarely been described in the literature.
Report of Cases | Six nails with dermatophytoma were imaged using a VivoSight Dx dermatologic optical coherence tomography (OCT) scanner (Michelson Diagnostics Ltd), a multiple-
Figure. A Pregnant 35-Year-Old Woman With Stevens-Johnson Syndrome
This image shows erythema and epidermolysis of the torso. In addition, the genital mucosa showed hemorrhagic erosions. Letters made with microscopic evaluation of nail clippings demonstrating PAS-positive branching hyphae forming a dense mass and invading the nail plate. 3 In contrast to the multiple techniques used to diagnose onychomycosis, there are currently no standardized or effective means for the diagnosis of dermatophytoma, even though proper diagnosis has important clinical consequences. Dermatophytoma has been found to be a negative prognostic factor for mycological cure when treating onychomycosis. 4 Optical coherence tomography for nail imaging is a new and growing practice. Healthy nails have been described as having bandlike structures, with varying degrees of intensity and thickness, parallel to the nail surface and a clear demarcation between the nail plate and bed. 5 Abuzahra et al 6 describe OCT findings of onychomycosis as a loss of differentiation of the distinct parallel bands seen in healthy nails and the presence of multiple, irregular, high-scattering, elongated structures parallel to the surface, corresponding to accumulations of fungal hyphae, surrounded by inhomogeneous low-scattering regions. 6 In the present study, OCT findings of nails with dermatophytoma were distinct from those of both healthy nails and nails with onychomycosis. We believe the presence of a sharply demarcated avascular mass lying within an inhomogeneous nail plate without distinct parallel bands and just above the nail bed represents onychomycosis complicated by dermatophytoma. These findings are quickly and easily visualized using structural and dynamic OCT.
Cutaneous Diphtheria Mimicking Pyoderma Gangrenosum
Pyoderma gangrenosum (PG) is an inflammatory, noninfectious neutrophilic dermatosis that presents as painful nodules or pustules that rupture and form a necrotic ulcer with an irregular undermined violaceous border. The full list of differential diagnoses must be considered and excluded by clinicians before diagnosing PG to avoid erroneous treatments with systemic corticosteroids or other immunosuppressants. 1 We report the case of a patient who presented with lesions that were identical to those found in PG but that occurred secondary to cutaneous diphtheria (CD).
Report of a Case | An adult woman with a medical history of hypertension and dyslipidemia presented with extremely painful ulcers on her legs. She reported that they had appeared after insect bites during a recent trip to West Africa. Nodules and ulcers developed in the following 2 weeks. A course of amoxicillin/clavulanate was prescribed with no clinical improvement.
On physical examination, 3 large ulcers with an irregular violaceous border and multiple tender nodules were observed on both legs (Figure 1 ). Blood analysis showed leukocytosis with neutrophilia and an elevated level of C-reactive protein. A punch biopsy and swab cultures for bacteria and fungi were performed. Hematoxylin-eosin stain showed dense perivascular and interstitial neutrophilic infiltrates in the superficial and deep dermis (Figure 2) . Additionally, a monoclonal IgG-lambda band was detected both in serum and urine. With all these findings, a diagnosis of PG was highly suspected. However, treatment with systemic corticoids was not begun; rather, the empirical antibiotic regimen of ceftriaxone and clindamycin was maintained, awaiting culture results.
In the following days Corynebacterium diphtheriae and Arcanobacterium hemolyticum were found to grow in the patient's blood agar swab culture. The identification was made with matrix-assisted laser desorption/ionization timeof-flight (MALDI-TOF) and confirmed by 16S rRNA and gene sequencing. A diagnosis of CD was made. To identify toxigenic strains of C diphtheriae, polymerase chain reaction analysis and oropharyngeal swab cultures were also performed, both yielding negative results. The patient was treated with oral azithromycin, 500 mg, once daily for 10 days and showed rapid clinical improvement. A new swab culture obtained from the patient's ulcers after completion of antibiotic therapy was negative. At 5-month follow-up, the patient remained asymptomatic.
Discussion | Up to 10% of PG cases are wrongly diagnosed. 1 There are no specific laboratory findings or diagnostic histo- Cutaneous diphtheria is caused by C diphtheriae and usually affects inhabitants or travelers from endemic developing countries. Coinfection with other pathogens such as Streptococcus pyogenes or A hemolyticum is frequent. 2, 3 Cutaneous diphtheria presents as painful nodules or nonhealing ulcers, and it can be highly contagious. 4 Recently, an outbreak among refugees from Africa and Syria was reported in Germany and Switzerland. 5 Early diagnosis is essential for preventing outbreaks of this disease. Treatment of CD differs from systemic diphtheria. It is based on systemic antibiotics like penicillin and erythromycin and isolation precautions. The lack of response to amoxicillin/clavulanate in our patient could be explained by the occasional resistance to penicillin that has been reported. 6 We describe a patient with CD resembling PG clinically and histologically. Strikingly, the patient also presented with a monoclonal IgG band, making the PG diagnosis even more plausible. However, the presence of conditions associated with PG such as inflammatory bowel disease, myeloproliferative disorders, or paraproteinemia has been described in almost 40% of patients misdiagnosed as having PG. 1 Clinicians must remember that PG is a diagnosis of exclusion, and it is mandatory to perform biopsies, cultures, and blood analysis to rule out neoplasms, infections, vascular, or autoimmune disorders.
Human Herpesvirus 8-Associated Inflammatory Cytokine Syndrome
Human herpesvirus 8 (HHV8) is the etiological agent of Kaposi sarcoma (KS), primary effusion lymphoma, human immunodeficiency virus (HIV)-associated multicentric Castleman disease (MCD), and the recently described KS herpesvirus-associated inflammatory cytokine syndrome (KICS).
1-4
Report of a Case | A man in his 50s with HIV infection and undergoing antiretroviral therapy with stable immune status developed a progressive KS in spite of pegylated-liposomal Three large ulcers with irregular, violaceous, and undermined borders, necrotic areas, and multiple nodules were observed on both legs.
Figure 2. Histologic Image
Perivascular and interstitial infiltrates in the deep dermis are exclusively formed by neutrophils and nuclear dusts (hematoxylin-eosin, original magnification ×200).
doxorubicin treatment (Figure) . He presented with selfresolving episodes of high fever, respiratory distress, hemodynamic instability, pancytopenia, and acute-phase reactant elevation. Although these indications were initially interpreted as infectious processes, no microorganisms were isolated, and soon hemophagocytic lymphohistiocytosis (HLH) was demonstrated. By nested polymerase chain reaction analysis, HHV8 viremia peaks were evidenced to coincide with the successive episodes of pancytopenia, hypertriglyceridemia, hyperferritinemia, hepatosplenomegaly, elevation of CD25, and bonemarrow hemophagocytosis. Image tests and histopathologic findings excluded MCD; thus, the diagnosis of KICS was established. In light of the rapid disease progression, rituximab and valganciclovir were added to the therapeutic regimen achieving a good response, with no more HLH episodes. Patient remained in remission at 1-year follow-up.
Discussion | Just as with other herpesviruses, HHV8 has a latency phase and a lytic phase. During the lytic phase, the whole genomic machinery is deviated toward the production of viral proteins, including the codification of a viral interleukin (vIL)-6.
1,2,4 This vIL-6 and its homologous human IL-6 are believed to initiate a host's cytokine cascade, inducing a disproportionate inflammatory response in patients with HIV-related MCD. [2] [3] [4] In 2010, Uldrick et al 4 noted the existence of a group of 6 patients with HHV8 and HIV coinfection whose symptoms overlapped those of MCD but who did not present with the typical lymphadenopathies. However, IL-6 and HHV8 levels in the studied group were comparable to those of an MCD cohort and substantially higher than those in controls with HHV8 infection or KS alone. Consequently, they described KICS as a separate entity with alleged similar etiopathogenesis to MCD and a high mortality rate (about 50%) (Box). Furthermore, we have demonstrated the existence HLH along with the exacerbation periods. Herpesviruses are known etiological agents of HLH, and there are several HHV8-related cases in the literature, not only in patients with HIV but also those with congenital immunodeficiency or transplant recipients. 5 Fardet et al 5 describe a series of 5 patients with HIV who experienced recurrent episodes of HLH coinciding with reactivations of their HHV8 infection. The clinical picture recounted by these authors resembles that of the present case and the one described as KICS. In our opinion, the existence of HLH could justify all KICS clinical manifestations. KICS, MCD, and HHV8-related recurrent HLH could be considered different manifestations of the same disease spectrum mediated by lytic reactivation of KS herpesvirus. 6 The researchers characterize the condition by a systemic inflammatory response in addition to leak syndrome features, with edema and pulmonary infiltrates leading to respiratory distress and eventual death. 1, 3, 4 We believe that KICS might be underdiagnosed, mistaken for septic shock in immunocompromised patients. There are no standard recommendations for its management, though a parallel approach to MCD seems logical, trying to maintain the balance between immunosuppression and tumor control. 1 The refractory nature of KS is a constant, probably in relation to IL-6 promotion of spindle-cell proliferation. The combination of the anti-CD20 agent rituximab, targeting the B-cell viral reservoir, 4 PLD directed to KS suppression, and the antiviral drug valganciclovir 3 led to prolonged remission in the present case. New therapies such as tocilizumab or sirolimus may represent a future alternative. 1, 3 Dermatologists should be aware of HHV8-related diseases and suspect
Figure. Kaposi Sarcoma Lesions
Erythematoviolaceous plaques involving the patient's legs.
Box. KICS Diagnostic Criteria a
At least 2 clinical manifestations from at least 2 categories (1 A, B, and C) are required for a KICS diagnosis, together with each of the criteria in 2, 3, and 4.
